Table 1 |
|
|
Baseline Vitiligo European Task Force characteristics of participants starting treatment |
|
|
Sex |
|
|
Female |
8 |
|
Male |
4 |
|
Mean Years of Age (range) |
18 (12-29) |
|
Fitzpatrick's phototypes |
|
|
I |
1 |
|
II |
0 |
|
III |
0 |
|
IV |
2 |
|
V |
9 |
|
VI |
0 |
|
Duration of disease, mean years (range) |
5.96 (2-17) |
|
Ethnicity |
|
|
Caucasian |
2 |
|
South Asian |
9 |
|
South American |
1 |
|
Disease activity |
|
|
Progressive |
7 |
|
Non progressive |
5 |
|
Previous repigmentation |
|
|
after treatment |
11 |
|
spontaneous |
0 |
|
no repigmentation |
1 |
|
Depigmentation on scars |
5 |
|
Stress at onset |
2 |
|
Stress as precipitating factor |
2 |
|
Itch before lesions |
3 |
|
Vitiligo on genitals |
3 |
|
Thyroid disease |
|
|
Yes |
1 |
|
No |
11 |
|
Thyroid antibodies |
|
|
Yes |
0 |
|
No |
9 |
|
unknown |
3 |
|
Family history of premature gray hair |
4 |
|
Family history of vitiligo |
3 |
|
Degree to which vitiligo affects everyday life (out of 10, 10 being the worst) (SD) |
3.7 (1.84) |
|
History of autoimmune disease |
0 |
|
Family history of thyroid or other autoimmune disease |
1 |
|
Halo Nevus |
0 |
|
|
|
|
n = 12, SD = standard deviation. |
|
|
Szczurko et al. BMC Complementary and Alternative Medicine 2011 11:21 doi:10.1186/1472-6882-11-21 |
|
